Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response
{{output}}
Hyperphagia is a hallmark of both congenital and acquired rare melanocortin-4 receptor (MC4R) pathway diseases. Currently, the medical community has no standard treatment guidelines or approach to establishing treatment benefit. This narrative review discusses... ...